Showing results (1-10 of 1,887) with videos related to

Sort By:
Pageof 189
International Journal of Oncology|May 18, 2011
The galactoside-specific lectin from mistletoe as biological response modifierS Gabius, S Joshi, K Kayser, et al.
Die Naturwissenschaften|December 1, 1995
[Protein-carbohydrate recognition. Foundation and medical application with illustrations of tumor lectin studies]H J Gabius, K Kayser, S Gabius
Zentralblatt Fur Pathologie|January 1, 1991
[Biotinylated ligands for receptor localization. An alternative for immunohistochemistry]K Kayser, H J Gabius, S Gabius
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1992
Analysis of tumour necrosis factor alpha-specific, lactose-specific and mistletoe lectin-specific binding sites in human lung carcinomas by labelled ligandsK Kayser, H J Gabius, S Gabius, et al.
Oncology Reports|July 30, 1999
Evaluation of histochemical anthracyclin binding as potential prognostic parameter in small cell lung cancerK Kayser, G Kayser, S Andre, et al.
International Journal of Oncology|May 3, 2011
Disease type-associated increases of the plasma levels and ligand expression for natural alpha- or beta-galactoside-binding immunoglobulin G subfractions in patients with lung cancerX Dong, S Andre, B Hofer, et al.
Histology and Histopathology|April 1, 1993
Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectinsH J Gabius, S Gabius, T V Zemlyanukhina, et al.
Biochemical and Biophysical Research Communications|May 31, 1990
Carrier-immobilized derivatized lysoganglioside GM1 is a ligand for specific binding sites in various human tumor cell types and peripheral blood lymphocytes and monocytesS Gabius, K Kayser, K P Hellmann, et al.
Anticancer Research|March 1, 1991
Establishment, characterization and determination of cell surface sugar receptor (lectin) expression by neoglycoenzymes of a human myeloid marker-expressing B lymphoblastoid cell lineS Gabius, S S Joshi, H J Gabius, et al.
Pathology, Research and Practice|November 1, 1993
Detection of the lymphokine migration inhibitory factor in normal and disease-affected lung by antibody and by its major binding protein, the interferon antagonist sarcolectinK Kayser, C Zeilinger, F Y Zeng, et al.
Pageof 189